Sapropterin dihydrochloride
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
This article summarizes the present knowledge, recent developments, and common pitfalls in the diagnosis, classification, and…
Fenilketonuri onlenebilir mental retardasyonun en onemli nedeni olan
kalitsal metabolik hastaliktir. Gectigimiz on yila kadar bu…
Healthcare systems worldwide are dealing with the uncertainty characterizing new and expensive health technoLogies, particularly…
Sapropterin dihydrochloride(Kuvan) is a synthetic dihydrochloride salt from the naturally occurring BH4.Kuvan can activate PAH…
Sapropterin dihydrochloride于2007年12月13日获得美国FDA批准上市，为四氢生物喋呤（BH4）类药物，最初由Asubio Pharma公司研发，商品名为Kuvan。本品为口服制剂（片剂规格为100mg／片^[1…
volume 26 number 11 november 2008 nature biotechnology had “peeled out of his skin and was shedding his intestinal lining,” Mills…
BioMarin Pharmaceutical Inc. and FDA announced in mid-December that the agency approved the marketing of a drug that may help up…